Associated Press, November 21, 2017
Stephen Braun

Links

Read the Full Article

WASHINGTON (AP) — Newly disclosed financial records show that President Donald Trump’s nominee to become Health and Human Services secretary reaped big earnings during his tenure as a top pharmaceutical executive.

As a top drug industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth $9.5 million to $20.6 million, and he was paid nearly $2 million in his final year at the company.

Azar was a former general counsel and deputy secretary at HHS during President George W. Bush’s administration. If confirmed, he would replace Tom Price, who resigned under pressure after using private charter flights at taxpayer expense. [...]

Read the full article here

health care reform health law policy regulation